Opko Health, Inc. (NASDAQ:OPK) will hold its 3Q20 earnings conference call with the financial community on 29th October 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.opko.com
Earnings Expectation
Opko Health, Inc. is reporting third quarter earnings results on Thursday 29th October 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.05 per share from $ 376.42 million in revenue. For the full year, analysts predict revenues of $ 1284.34 million, while looking forward to income of $ 0.05 per share.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The companys Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform.
